North America Blood Culture Tests Market

North America Blood Culture Tests Market Size

The size of the North America blood culture tests market was worth USD 25.93 billion in 2024. The regional market is anticipated to grow at a CAGR of 9.32% from 2025 to 2033 and be worth USD 57.82 billion by 2033 from USD 28.35 billion in 2025.

MARKET DRIVERS

Tech Advancements and Rising R&D in Blood Culture Tests

Technological advancements in this area are majorly accelerating the North American blood culture tests market. It helps the blood culture tests provide superior quality, accuracy, and reliability in diagnosing the diseases and evading unnecessary healthcare costs, adding fuel to this region's growth. Growing R & D activities for novel products, increasing healthcare expenditure by public and private organizations, uplifts the development of the U.S. blood culture tests market. The increasing adoption rate of the latest technologies in patients, including multiplex real-time PCR system, molecular method and mass spectrometry, and electrospray ionization. Also, growth in government and private organizations makes proposals to bring out the awareness in people about the bacteria borne health conditions driving the market growth in the region.

MARKET RESTRAINTS

High Test Costs and Shortage of Skilled Technicians

The blood culture tests cost is increasing as 250,000 bloodstream infections are occurring every year, leading to the cause of suffering and deaths as the death rate goes up to 35% and costs massive per test in the U.S., which is expected to be hindering the market growth during the forecast period. The scarcity of experienced laboratory technicians is limiting the blood culture tests market over the period. Lack of reimbursement policies is impeding the market.

REPORT COVERAGE

REGIONAL ANALYSIS

North America held the largest share in the market due to many large healthcare companies' local presence. Also, growing investments in R&D by manufacturers for new product development in this region is expected to propel the growth of the industry. In Canada, about 8,000 patients die annually because of hospital-acquired infections. According to WHO, about 250,000 cases of BSIs occur yearly in the U.S., and among them, around 80,000 patients in ICUs suffer from catheter-related BSIs. As a consequence, there is a high demand for advanced test products by hospitals and clinical diagnostics laboratories for the detection of bacterial, fungal, and mycobacterial infections.

KEY MARKET PLAYERS

Some of the companies dominating the North American Blood Culture Tests market analyzed in this report are Cepheid, Inc., Nanosphere Inc., Becton, Dickinson and Company, bioMérieux SA, Thermo Fisher Scientific Inc., IRIDICA, Beckman Coulter, Bruker Corporation, and T2 Biosystems.

MARKET SEGMENTATION

This research report on the North American Blood Culture Tests Market has been segmented & sub-segmented into the following categories:

By Product:

• Consumables
  • Blood Culture Media
    • Aerobic Blood Culture Media
    • Pediatric Aerobic Blood Culture Media
    • Anaerobic Blood Culture Media
    • Mycobacterial Blood Culture Media
    • Fungi Blood Culture Media
  • Assay Kits & Reagents
  • Blood Culture Accessories
• Instruments
  • Automated Blood Culture Systems
  • Supporting Laboratory Equipment
    • Incubators
    • Colony Counters
    • Microscopes
    • Gram Stainers
• Software and Services

By Technology:

• Culture-Based Technology
• Molecular Technologies
  • Microarrays
  • PCR (Polymerase Chain Reaction)
  • PNA-FiSH (Peptide Nucleic Acid – Fluorescent in Situ Hybridization)
• Proteomics Technology

By Application:

• Bacteremia
• Fungemia
• Mycobacterial Detection

By End User:

• Hospital Laboratories
• Reference Laboratories

By Country:

• The United States
• Canada
• Rest of North America